Menu
Innovation Observatory > Reports > Drugs > VF-001 (VitroGro ECM) for venous leg ulcer

< Back

VF-001 (VitroGro ECM) for venous leg ulcer

Drugs

Cancer and Palliative Care

June 2017


VF-001 is a new drug that enables and accelerates chronic wound repair by providing cell attachment sites and stimulating cell activity. Consequently, skin cells are able to attach, migrate and increase rapidly to restore the wound healing process.VF-001 is applied to the wound weekly, and fits with standard care for chronic wounds. The wound closes, breaking the cycle of inflammation, and leaving healthy, functional tissue.

Innovation Observatory Voice 0

Leave a Reply

Your email address will not be published. Required fields are marked *

Post Comment

Connect to the Innovation Observatory

Twitter

 

Related Information



Load More Related Posts
Get Alerts